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54 The Journal of Thoracic and CardiovObjective: Systemic inflammatory response syndrome and infectious complications
are major causes of morbidity and mortality after cardiopulmonary bypass. Recent
work in adult patients suggests that the balance between proinflammatory and
anti-inflammatory mediators is important. We hypothesized that the expression of
different function-related receptors on circulating monocytes might reflect the net
response of the inflammatory reaction.
Methods: We performed a prospective and observational study in a tertiary pediatric
cardiac center in a population of children (n  40) undergoing elective cardiac
surgery. Expression of receptors on the surface of monocytes was assessed before,
during, and after surgical intervention.
Results: Early monocyte activation was demonstrated by changes of the expression
of the chemokine receptor CCR2, which was inversely correlated with plasma levels
of monocyte chemotactic protein 1 (rho  0.54, P  .002). High levels of
monocyte chemotactic protein 1 were found in children with high expression of the
adhesion receptor CD11b/CD18 on circulating monocytes. The intensity of human
leukocyte antigen DR expression rapidly decreased in all children after the onset of
cardiopulmonary bypass (P  .001). Low human leukocyte antigen DR expression
was correlated with increased plasma levels of interleukin 10 postoperatively.
Children who had signs of bacterial pneumonia postoperatively had lower levels of
human leukocyte antigen DR expression before surgical intervention (relative risk,
13.3; P  .007).
Conclusions: The expression of monocyte function–related receptors is altered after
cardiac surgery. Early activation of monocytes by monocyte chemotactic protein 1
possibly released from the heart is followed by an anti-inflammatory response with
suppression of monocyte human leukocyte antigen DR expression. The increased
risk of bacterial infection after pediatric cardiac surgery can be anticipated by
surveillance of monocyte function before surgical intervention.
Cardiac surgery with cardiopulmonary bypass (CPB) provokes the systemicinflammatory response syndrome (SIRS), which is a major cause of mor-bidity and mortality. The orchestrated recruitment of leukocytes is a fun-
damental characteristic of the inflammatory response. In this process monocytes are
thought to play a key role by releasing a variety of proteases, cytotoxic proteins, and
oxidants leading to tissue damage and by producing proinflammatory and anti-
inflammatory cytokines that might amplify or suppress the inflammatory reaction.
The CD14 molecule is one of the most characteristic surface antigens of the
monocyte lineage. CD14 is highly expressed on the surface of monocytes and is
strongly upregulated during the differentiation of monocytic precursors into mono-
cytes. Functionally, CD14 is a receptor for the complex of lipopolysaccharide and
its binding protein.1 On the basis of the intensity of CD14 expression, blood
monocytes can be separated into 2 subpopulations. The majority of blood mono-
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Dcytes express CD14 at a high density (CD14bright), whereas
approximately 10% to 15% of monocytes express this an-
tigen at a lower level (CD14dim).2,3 The expression of func-
tion-related antigens is different among these monocyte
subpopulations.3,4
Monocytes serve an important function in cell-to-cell
interaction as antigen-presenting cells. They bear the class II
glycoproteins of the major histocompatibility complex gene
complex: human leukocyte antigen (HLA) DR, HLA-DP,
and HLA-DQ. HLA-DR expression on monocytes is in-
creased by interferon  and granulocyte-macrophage colo-
ny-stimulating factor, whereas tumor necrosis factor , en-
dotoxin, interleukin (IL) 10, and glucocorticoids
downregulate HLA-DR expression.5-8 Decreased HLA-DR
antigen expression on blood monocytes has been shown
after severe trauma or major operations in adults correlating
with the presence or the development of major infection.9
Moreover, low monocyte HLA-DR expression has been
postulated to serve as a predictive parameter for clinical
outcome in adults with sepsis10,11 and as a prognostic pa-
rameter in pediatric cardiac surgery.12
In addition to their major histocompatibility complex
class II molecules, monocytes express multiple surface ad-
hesion molecules, including CD11b/CD18 (Mac-1).
CD11b/CD18 is critical for adhesion and transendothelial
migration. Expression of CD11b/CD18 on circulating neu-
trophils is decreased in critically ill patients with SIRS13 and
after CPB.14 However, no data about CD11b/CD18 expres-
sion on circulating monocyte subpopulations after CPB are
available.
Monocytes have the ability to orient and move along a
chemical gradient. Chemokines are important mediators of
chemotactic and migratory behavior. These 8- to 10-kd
molecules are subdivided into families on the basis of the
relative position of the N-terminal cysteine residues in the
mature protein (CXC, CC, C, and CX3C chemokines). The
effects of chemokines on leukocytes are mediated by recep-
tors that belong to the 7-transmembrane, G protein–cou-
pled, cell-surface receptors. After stimulation, the receptors
are rapidly internalized and subsequently recycled to the
plasma membrane or degraded. Downregulation of recep-
tors might therefore be an indicator of in vivo exposure of
the leukocyte to the corresponding agonist.15 Whereas CXC
chemokines, such as IL-8, act primarily on neutrophils, CC
chemokines are potent activators of monocytes. Monocyte
chemoattractant protein (MCP) 1, the prototype CC chemo-
kine, is a potent monocyte chemoattractant that functions by
interacting with the receptor CCR2, which is constitutively
expressed on these cells.
The aim of the present prospective work was to investi-
gate the expression of different membrane receptors on
circulating monocytes with respect to monocyte function in
this human in vivo model of systemic inflammation. We
The Journal of Thorachypothesized that reduced HLA-DR expression reflects an
anti-inflammatory state that might be a risk factor in the
development of infectious complications. In contrast, a pre-
dominantly proinflammatory monocyte reaction might pre-
dispose the patient to increased cardiovascular impairment
after CPB.
Materials and Methods
Patients and Blood-sampling Protocol
The study was approved by the local ethics committee. Informed
written consent from the parents of each child was obtained. The
studied population included 40 consecutive patients for scheduled
cardiac surgery. Only children older than 3 months and younger
than 7 years were included. Patients’ data are shown in Table 1.
All patients were breathing spontaneously. Preoperative levels of
lactate were within the normal range (1.1  0.6 mmol/L), and
there were no signs of infection (mean levels of C-reactive protein,
7.1  4.2 mg/L).
All children received antibiotic prophylaxis at the start of the
operation and 12 hours thereafter (cefazolin dose, 25 mg/kg).
Blood cultures were taken at the treating clinician’s discretion if
there was a clinical concern about sepsis or body core temperature
of greater than 38.5°C. All episodes of suspected infections were
recorded, but for the calculation of the incidence of infectious
complications, only 5 days postoperatively were taken into ac-
count. Pneumonia was defined as the presence of infiltrates on a
chest radiograph plus purulent tracheobronchial secretions (Gram
staining) together with positive microbial findings.
Arterial blood samples for immunophenotyping of cells, as well
as for cytokine assays, were collected from each patient before
CPB (after induction of anesthesia with midazolam, fentanyl, and
pancuronium), during CPB (30 minutes after the start of CPB), and
at 1 and 3 hours after the end of CPB. Measurements of cell
receptors were done immediately after sample collection. Blood
samples for cytokine assays were immediately centrifuged, and the
plasma was stored at 80°C.
CPB Management
The extracorporeal circuit consisted of a roller pump, cardiotomy
TABLE 1. Patient characteristics
Age (mo) 11 (3-83)*
Body weight (kg) 7.5 (3.5-24.4)
Left-to-right shunt lesions† n  16
Obstructive lesions‡ n  9
Cyanotic congenital heart defects§ n  15
Cardiopulmonary bypass time (min) 132 (67-345)
Aortic crossclamp time (min) 39 (0-205)
*Data are presented as medians and ranges. †Atrial septal defect (n  7),
ventricular septal defect (n  5), complete atrioventricular canal (n  4).
‡Aortic stenosis (n  7), pulmonary stenosis (n  2). §Single ventricle (n
 3), hypoplastic left heart syndrome (n  3), tetralogy of Fallot (n  4),
double-outlet right ventricle (n  2), congenitally corrected transposition
of the great arteries (n  1), tricuspid atresia (n  1), total anomalous
pulmonary venous return (n  1).reservoir, tubing set, and oxygenator. The circuit was primed with
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Da mixture of filtered red blood cell concentrate (leukocytes 1 
10E6 per unit), human albumin, sodium bicarbonate 8.4%, man-
nitol 20%, magnesium chloride, aprotinin (250,000 U/kg body
weight; Bayer, Leverkusen, Germany), and heparin (Roche
Pharma, Grenzach, Switzerland). It should be pointed out that
aprotinin was used in all patients, and the dosage was consistent in
all patients. Patients weighing less than 7 kg received 30 mg/kg
prednisolone (UltracortenH; Novartis Pharma, Basel, Switzerland)
administered into the CPB priming solution immediately before
the start of CPB according to our currently used standard treatment
protocol. Cardioplegic solutions were the standard Buckberg po-
tassium-based solutions (pharmacy of the canton of Zurich) mixed
with blood. The extracorporeal circuit flow rates were between 2.4
and 2.8 L · min1 · m2. Ultrafiltration was performed in all
patients in a standardized manner during the rewarming period by
using a blood concentrator (20 mL/min, resulting in a volume of
800  400 mL). The injected heparin was neutralized with prota-
mine hydrochloride (ICN Pharmaceuticals, Frankfurt, Germany)
after the end of CPB.
Flow Cytometry of Blood Leukocytes
Cell-surface receptors were detected with a standard technique for
immunophenotyping. Arterial blood anticoagulated with ethyl-
enediamine tetraacetic acid was used, and measurements were
done immediately after sample collection. Saturating amounts of
the following fluorescent monoclonal antibodies (mAbs) were
used: fluorescein isothiocyanate–conjugated mouse anti-human
CD14 (clone M5E2), anti-CD16–fluorescein isothiocyanate (clone
3G8), phycoerythrin (PE)–conjugated mouse anti-human CD11b/
MAC-1-PE (clone ICRF44), anti-HLA-DR-PE (clone L243) mAb,
and isotype-matched controls (BD Biosciences Pharmingen, San
Diego, Calif), as well as anti-human CCR2-PE (clone 48607.211)
mAb (R&D Systems, Minneapolis, Minn). Fixation of leukocytes
and lysis of erythrocytes was done with FACS-lysing solution (BD
Biosciences). For calibration of the measurements and for an
Figure 1. Expression of CCR2 (RFI) on CD14 bright (striped bars)
and CD14dim (dotted bars) monocytes during the study period.
Values are expressed as means  standard deviation. **P < .01
and ***P < .001, analysis of variance for repeated measurements
and paired t tests with the Bonferroni correction.estimation of the number of PE molecules bound per cell (PE per
56 The Journal of Thoracic and Cardiovascular Surgery ● July 2cell), beads conjugated with known levels of PE were used (Quan-
tiBRITE PE, BD Biosciences). A total of 10,000 cells were ac-
quired per measurement by using a FACSCalibur flow cytometer
with CellQuest analysis software (BD Biosciences). The cells were
analyzed for their fluorescence properties, and results were ex-
pressed as relative fluorescence intensity (RFI). RFI values are
directly proportional to the respective expression of the receptors
on the cell surface.
Plasma Levels of MCP-1, IL-8, and IL-10
Plasma concentrations of MCP-1, IL-8, and IL-10 were measured
with a commercial enzyme-linked immunosorbent assay kit
(Quantikine, R&D Systems) according to the manufacturer’s
recommendations.
Data Analysis
Statistical analysis was performed with SPSS and GraphPad InStat
3. Unless otherwise stated, numeric results are presented as means
 standard deviation. Two-tailed tests were used for all statistical
comparisons. Data for some variables were logarithmically trans-
formed to be approximately normally distributed. Analysis of the
data at the different time points was performed with analysis of
variance for repeated measurements. Paired t tests with the Bon-
ferroni correction were then performed as post-hoc tests to com-
pare the different time points. For comparisons between monocyte
subpopulations at the different time points, paired t tests with the
Bonferroni correction were performed. Correlations between con-
tinuous variables were assessed by using the Spearman rho corre-
lation coefficient. Fisher exact tests have been used to compare
patients with and without pneumonia with respect to dichotomized
versions of HLA-DR. Mann-Whitney exact tests have been used to
compare patients with and without pneumonia with respect to
continuous outcomes.
Results
CPB Is Followed by Diminished CCR2 Expression on
Monocytes
Separation of monocytes into 2 subsets according to their
level of CD14 antigen expression, CD14bright and CD14dim,
showed that the percentage of CD14bright monocytes before
CPB was 90.5%  4.3% and that this percentage remained
unchanged during and after CPB (data not shown). CPB
resulted in diminished CCR2 expression on both monocyte
subpopulations that lasted at least 3 hours after CPB (Figure
1). The reduction of CCR2 expression was significantly
more marked in CD14dim monocytes than in CD14bright
monocytes. The surface expression of CCR2 on CD14bright
monocytes showed a negative correlation to the plasma
levels of MCP-1 (rho  0.50 and P  .004 at 1 hour after
CPB and rho  0.54 and P  .002 at 3 hours after CPB,
respectively; Figure E1). Plasma levels of MCP-1 were
strongly increased during and after CPB (before CPB, 169
 152 pg/mL; during CPB, 363  665 pg/mL; 1 hour after
CPB, 2326 2851 pg/mL; 3 hours after CPB, 1846 2882
pg/mL; P  .001). This increase was not significantly
influenced by the age of the children.
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DExpression of Adhesion Molecule CD11b/CD18
Strongly Correlates With Plasma Levels of MCP-1
and IL-8 After CPB
CD11b/CD18 is expressed on 99.9%  0.1% of circulating
monocytes. As expected, the density of CD11b/CD18 ex-
pression on CD14bright monocytes was higher than on
CD14dim monocytes (P  .001, Figure E2). During CPB,
expression of CD11b/CD18 on CD14bright monocytes was
significantly reduced. There was a significant correlation
between CD11b/CD18 expression on CD14bright monocytes
and MCP-1 plasma levels at 1 and 3 hours after CPB (1 hour
after CPB, rho 0.50 and P .003; 3 hours after CPB, rho
 0.62 and P  .001; Figure E3). Moreover, at 1 and 3
hours after CPB, the density of CD11b/CD18 expression on
CD14bright monocytes was also correlated with plasma lev-
els of IL-8 (1 hour after CPB, rho  0.60 and P  .001; 3
hours after CPB, rho  0.59 and P  .001, respectively).
Plasma levels of IL-8 were increased after CPB (1 hour after
CPB, 152.0  297.3 pg/mL; 3 hours after CPB, 134.2 
179.0 pg/mL; P  .001) and were correlated with the
duration of CPB (1 hour after CPB, rho  0.62 and P 
.001; 3 hours after CPB, rho  0.51 and P  .004). In
contrast, the lowest body temperature during CPB and the
age of the children was not significantly correlated with
IL-8 levels.
The Postoperative Reduction of HLA-DR Expression
on CD14dim Monocytes Correlates With Plasma IL-10
Levels
HLA-DR is expressed on 98.5%  2.0% of circulating
monocytes. During and after CPB, the RFI of HLA-DR
Figure 2. Expression of HLA-DR (RFI) on CD14bright (striped bars)
and CD14dim (dotted bars) monocytes during the study period.
Values are expressed as means  standard deviation. ***P <
.001, analysis of variance for repeated measurements and paired
t tests with the Bonferroni correction.expression decreased for both CD14bright and CD14dim
The Journal of Thoracmonocytes (Figure 2). However, the expression of HLA-DR
on CD14bright monocytes remained consistently much lower
than on CD14dim monocytes (P  .01). The age of the
children did not contribute significantly to the observed
decrease of HLA-DR expression after the onset of CPB.
Calculating the number of bound PE labels of HLA-DR on
CD14bright monocytes, an RFI value of 176  58 before
CPB corresponds to 31,640  10,427 PE labels per cell. In
contrast, HLA-DR expression on CD14dim monocytes be-
fore CPB was much higher (RFI value of 396  187,
corresponding to 69,306  33,499 PE labels per cell).
Plasma levels of IL-10 were strongly increased after
CPB compared with preoperative values (before CPB, 14.9
 23.2 pg/mL; during CPB, 20.4  25.2 pg/mL; 1 hour
after CPB, 379.2  444.3 pg/mL; 3 hours after CPB, 180.5
 197.0 pg/mL; P  .001). No statistically significant
correlation was detectable between postoperative plasma
concentrations of IL-10 and the expression of HLA-DR on
CD14bright monocytes. In contrast, there was a significant
negative correlation between postoperative levels of IL-10
and the surface expression of HLA-DR on CD14dim mono-
cytes (rho  0.35 and P  .032 at 1 hour after CPB and
rho 0.39 and P  .015 at 3 hours after CPB; Figure E4).
Cardiac Diagnosis Did Not Significantly Affect Levels
of HLA-DR Expression
The expression of HLA-DR on CD14bright monocytes in
patients with or without cyanotic heart lesions was equal
(HLA-DR expression in patients with cyanosis before CPB
Figure 3. Expression of HLA-DR (RFI) on CD14bright monocytes in
patients without (filled bars) and with (open bars) pneumonia
during the study period. Values are expressed as means 
standard deviation. *P < .05, analysis of variance for repeated
measurements and unpaired t tests with the Bonferroni
correction.was 163  48 RFI value, and that in patients without
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Dcyanosis was 184  63 RFI value, P  .245; during CPB,
113  59 vs 119  39 RFI; 1 hour after CPB, 77  34 vs
75  30 RFI; 3 hours after CPB, 90  38 vs 80  24 RFI,
respectively; P  .30). The same holds true for the expres-
sion of HLA-DR on CD14dim monocytes, with no statisti-
cally significant differences detectable in patients with and
without cyanotic heart lesions (data not shown). Low ex-
pression of HLA-DR on CD14bright and CD14dim monocytes
after CPB was not associated with an increased duration of
postoperative inotropic therapy or increased concentrations
of lactate.
Patients With Pneumonia Had Significantly Lower
HLA-DR Expressions Before Surgical Intervention
Than Patients Without Pneumonia
Related to infection, blood cultures were taken postopera-
tively from 19 patients, and 10 of these patients were treated
with antibiotics. None had a positive blood culture, but
tracheal mucus showed leukocytes plus positive bacterial
findings in 5 patients (Staphylococcus aureus n  3, in 2
patients together with Moraxella catarrhalis; Haemophilus
influenzae n 1, Pseudomonas aeruginosa n 1). Patients
with clinical and bacteriologic signs of pneumonia (n  5)
were younger than patients without signs of pneumonia (n
 34; median age of 5 months [range, 3-45 months] com-
pared with 15 months [range, 4-83 months], respectively; P
 .186), weighed less (median body weight of 4.5 kg
[range, 3.5-13.2 kg] compared with 10.1 kg [range, 4.0-24.4
kg], respectively; P  .021), and were treated with steroids
more often (4 of 5 patients with pneumonia compared with
19 of 34 patients without pneumonia, P  .63). One patient
was excluded because of death caused by cardiac failure at
24 hours after CPB (all other patients survived until dis-
charge). Cardiac diagnosis in both groups was quite heter-
ogeneous, and both CPB time and aortic crossclamp time
were statistically not different (data not shown). In patients
with pneumonia, the expression of HLA-DR on CD14bright
and CD14dim monocytes was lower compared with that seen
in patients without pneumonia (Figures 3 and E5). Patients
with HLA-DR expression on CD14bright monocytes before
CPB of less than 125 RFI value (corresponding to 22,655
PE labels per cell) had a relative risk of 13.3 (95% confi-
dence interval, 1.7-104.8) of later development of pneumo-
nia (sensitivity, 0.80; specificity, 0.85; positive predictive
value, 0.44; negative predictive value, 0.97; P  .007).
During CPB, a threshold of 75 RFI value (13,796 PE labels
per cell) was used for calculating test statistics (sensitivity,
0.80; specificity, 0.85; positive predictive value, 0.44; neg-
ative predictive value, 0.97; P  .007). Considering
HLA-DR expression on CD14dim monocytes, only the in-
tensity before CPB was useful in predicting the risk of
infection (relative risk, 6.9 [95% confidence interval, 1.4-
33.7]; sensitivity, 0.60; specificity, 0.88; positive predictive
value, 0.43; negative predictive value, 0.94; P  .032
58 The Journal of Thoracic and Cardiovascular Surgery ● July 2[threshold value used 225 RFI, corresponding to 40,086 PE
labels per cell]. Low expression of HLA-DR on CD14bright
and CD14dim monocytes after CPB was not associated with
an increased duration of postoperative inotropic therapy or
increased concentrations of lactate.
Therapy With Glucocorticoids Did Not Significantly
Affect Levels of HLA-DR Expression
Patients weighing less than 7 kg received glucocorticoids
administered into the priming solution of the CPB circuit.
Because steroids were administered into the priming solu-
tion of CPB, the time point before CPB actually reflects a
time when none of the patients received steroids. No sig-
nificant difference was detectable between HLA-DR ex-
pression on CD14bright monocytes and CD14dim monocytes
at any time during the study period (HLA-DR expression on
CD14bright monocytes in patients with steroids before CPB
was 164  47 RFI and in patients without steroids was 195
 69, P  .140; during CPB, 125  50 vs 104  39 RFI;
at 1 hour after CPB, 74  31 vs 79  32 RFI; at 3 hours
after CPB, 85  36 vs 80  15 RFI, respectively; P  .26,
HLA-DR expression on CD14dim monocytes, data not
shown).
Discussion
This study demonstrates that cardiac surgery with CPB in
children up to 7 years of age is associated with changes of
the expression of surface antigens on circulating monocytes,
which are correlated with changes of the monocyte function.
The clinical outcome with respect to postoperative devel-
opment of pneumonia was predicted by the level of
HLA-DR expression before surgical intervention.
The procedure of CPB resulted in significant reduction of
HLA-DR expression on CD14bright and CD14dim mono-
cytes, lasting for at least 3 hours postoperatively. Decreased
HLA-DR expression on circulating monocytes has been
reported after major trauma or surgical intervention, as well
as during the course of sepsis, reflecting monocyte deacti-
vation.9-11 In addition, a predictive value of HLA-DR ex-
pression has been shown, with low HLA-DR expression
correlating with poor outcome.16,17 Our observation of de-
creased HLA-DR expression after cardiac surgery confirms
previous results in adults18 and children.12 In addition and
noteworthy, we show that patients who experienced signs of
pneumonia postoperatively had significantly lower levels of
HLA-DR before the start of CPB. Only the time period of 5
days postoperatively was taken into account to assess the
incidence of infections in relation to HLA-DR expression
because infectious complications with nosocomial patho-
gens usually increase after a longer stay in the intensive care
unit, irrespective of the underlying disease. Taking our data,
the intensity of HLA-DR expression before CPB can be
used to calculate the relative risk of postoperative develop-
ment of pneumonia.
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DIn the present study only infants older than 3 months of
age were included because reduced HLA-DR expression
has been demonstrated in neonatal monocytes during the
first days of life.3,19,20 By using a method that allows for the
quantification of fluorescence intensity, the number of
bound anti-HLA-DR mAbs expressed per monocyte before
CPB was comparable with those values reported in adults.18
However, this holds true only when taking into account
CD14bright monocytes. The majority of circulating mono-
cytes express CD14 and HLA-DR at a high level, but about
10% of cells express CD14 at a lower level, along with
increased expression of HLA-DR.3 The population of
CD14dim monocytes with increased expression of HLA-DR
has been suggested to resemble cells that have acquired
features in common with more mature tissue macro-
phages.3,21 Moreover, the CD14dim HLA-DRhigh monocytes
show expression of a distinct pattern of cytokines compared
with CD14bright monocytes. In particular, they have been
shown in vitro to produce the proinflammatory cytokine
tumor necrosis factor, whereas they produce no or little of
the anti-inflammatory cytokine IL-10.4 An important find-
ing in the present study was the significant correlation
between plasma levels of IL-10 and HLA-DR expression on
CD14dim monocytes but not between levels of IL-10 and
HLA-DR expression on CD14bright monocytes. High levels
of IL-10 have been reported in patients with sepsis and
SIRS, and IL-10 has been identified as being a major
monocyte deactivator. In particular, IL-10 has been demon-
strated to downregulate the expression of HLA-DR on the
surface of monocytes in vitro.7,22 However, in vivo no
correlation between plasma levels of IL-10 and the surface
expression of HLA-DR on circulating monocytes after car-
diac surgery could be demonstrated.8 Our results are in
agreement with findings reporting IL-10–dependent
changes of HLA-DR expression according to the maturation
state of monocytes.23-25 This might at least in part be
responsible for conflicting results not taking into account
monocyte maturation and subpopulations.
Decrease of HLA-DR expression has been shown after
administration of steroids both in vitro26 and in vivo.27 In
contrast, steroid treatment of patients in our study had no
effect on HLA-DR expression of both monocyte subpopu-
lations. The difference might be due to the lower dose we
used or the time of administration of steroids.
A further observation of considerable interest was that
after CPB, the expression of CD11b/CD18 on monocytes
was correlated with plasma levels of MCP-1 and IL-8.
Because CD11b/CD18 rapidly decreases on cells main-
tained in vitro, we used a flow cytometric assay that allows
for the rapid quantification of receptor expression on the
surface of cells. The expression of CD11b/CD18 was higher
on CD14bright monocytes, confirming previously reported
data.3 The fact that one of the receptors for MCP-1, namely
The Journal of ThoracCCR2, was downregulated suggests that these cells were
stimulated by MCP-1.15 Indeed, we here document in vivo
a rapid and sustained downregulation of CCR2 on mono-
cytes along with increased plasma levels of MCP-1 during
and after CPB in children. MCP-1 has been demonstrated in
an animal model to be induced by myocardial ischemia and
reperfusion.28 Thus MCP-1 might play a fundamental role
in triggering an inflammatory reaction with recruitment and
activation of monocytes after CPB in children. Activated
monocytes in turn might release IL-8, as demonstrated by
the correlation between CD11b/CD18 and IL-8. We have
recently shown that the release of IL-8 and other proinflam-
matory cytokines was correlated with impairment of cardio-
vascular function.29
In conclusion, CPB in children induced rapid changes of
antigen expression on the surface of circulating monocytes.
The phenotypic changes are different among monocyte sub-
populations, suggesting different functions. The release of
MCP-1 might be an important trigger for the monocyte
inflammatory response, followed by the release of humoral
factors, such as IL-8 and IL-10. In cardiac surgery of
children, monitoring of preoperative HLA-DR levels might
be helpful in predicting an increased risk for postoperative
infectious complications.
We thank the parents and their children who allowed this study
to take place.
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DFigure E1. Correlation between the expression of CCR2 on CD14
bright monocytes (RFI) and plasma MCP-1 concen-
trations (in picograms per milliliter) determined 1 hour after CPB (A) and 3 hours after CPB (B); (1 hour after CPB,
rho  0.50 and P  .004; 3 hours after CPB, rho  0.54 and P  .002).
Figure E2. Expression of CD11b/CD18 (RFI) on CD14bright (striped bars) and CD14dim (dotted bars) monocytes during
the study period. Values are expressed as means  standard deviation. ***P < .001, analysis of variance for
repeated measurements and paired t tests with the Bonferroni correction.The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 1 60.e1
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DFigure E3. Correlation between the expression of CD11b/CD18 on CD14bright monocytes (RFI) and plasma MCP-1
concentrations (in picograms per milliliter) determined 1 hour after CPB (A) and 3 hours after CPB (B); (1 hour after
CPB, rho  0.50 and P  .003; 3 hours after CPB, rho  0.62 and P < .001).
Figure E4. Correlation between the expression of HLA-DR on CD14dim monocytes (RFI) and plasma IL-10 concen-
trations (in picograms per milliliter) determined 1 hour after CPB (A) and 3 hours after CPB (B); (1 hour after CPB,
rho  0.35 and P  .032; 3 hours after CPB, rho  0.39 and P  .015).60.e2 The Journal of Thoracic and Cardiovascular Surgery ● July 2005
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DFigure E5. Expression of HLA-DR (RFI) on CD14dim monocytes in
patients without (filled bars) and in with (open bars) pneumonia
during the study period. Values are expressed as means 
standard deviation*. P <. 05, analysis of variance for repeated
measurements and unpaired t tests with the Bonferroni
correction.The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 1 60.e3
